AAV vectors: The Rubik's cube of human gene therapy

A Pupo, A Fernández, SH Low, A François… - Molecular Therapy, 2022 - cell.com
Defective genes account for∼ 80% of the total of more than 7,000 diseases known to date.
Gene therapy brings the promise of a one-time treatment option that will fix the errors in …

Viral delivery systems for CRISPR

CL Xu, MZC Ruan, VB Mahajan, SH Tsang - Viruses, 2019 - mdpi.com
The frontiers of precision medicine have been revolutionized by the development of
Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR)/Cas9 as an editing …

Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model

O Akil, F Dyka, C Calvet, A Emptoz… - Proceedings of the …, 2019 - National Acad Sciences
Autosomal recessive genetic forms (DFNB) account for most cases of profound congenital
deafness. Adeno-associated virus (AAV)-based gene therapy is a promising therapeutic …

Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications

F Zhang, RAN Fei - US Patent App. 14/104,837, 2014 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
49883289&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

[HTML][HTML] Usher syndrome: Hearing loss, retinal degeneration and associated abnormalities

P Mathur, J Yang - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2015 - Elsevier
Usher syndrome (USH), clinically and genetically heterogeneous, is the leading genetic
cause of combined hearing and vision loss. USH is classified into three types, based on the …

Biology and therapy of inherited retinal degenerative disease: insights from mouse models

S Veleri, CH Lazar, B Chang… - Disease models & …, 2015 - journals.biologists.com
Retinal neurodegeneration associated with the dysfunction or death of photoreceptors is a
major cause of incurable vision loss. Tremendous progress has been made over the last two …

Delivery and use of the CRISPR-Cas systems, vectors and compositions for hepatic targeting and therapy

F Zhang, L Cong, RAN Fei - US Patent 10,577,630, 2020 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
52105121&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications

F Zhang - US Patent App. 14/183,512, 2014 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
49883289&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof

F Zhang, NE Sanjana, O Shalem - US Patent App. 14/463,253, 2014 - Google Patents
2020-03-09 Assigned to NATIONAL INSTITUTES OF HEALTH (NIH), US DEPT. OF HEALTH
AND HUMAN SERVICES (DHHS), US GOVERNMENT reassignment NATIONAL …

In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery

A Garanto, DC Chung, L Duijkers… - Human molecular …, 2016 - academic.oup.com
Leber congenital amaurosis (LCA) is a severe disorder resulting in visual impairment
usually starting in the first year of life. The most frequent genetic cause of LCA is an intronic …